文献速递胃肠外科围术期管理与 ERAS

腹膜透析导管置入作为肾脏替代治疗方式的长期结果:来自三级学术机构的数据

Peritoneal dialysis catheter placement as a mode of renal replacement therapy: Long-term results from a tertiary academic institution.
PubMed 文献 · Surgery · 2017-09-01

本文回顾性分析了2005年至2015年间采用最佳实践技术行腹腔镜腹膜透析导管置入的457例患者,评估其长期导管耐用性。结果显示30天再手术率为0.9%,无围手术期死亡,5.5年后30%患者从腹膜透析转为血液透析,中位肾移植时间为5.6年。作者推荐采用这些技术以促进导管长期存活。

要点

  • 采用最佳实践技术行腹腔镜腹膜透析导管置入,30天再手术率仅0.9%。
  • 长期随访中,5.5年后约30%患者从腹膜透析转为血液透析。
  • 从开始腹膜透析到肾移植的中位时间为5.6年。

核心结论

  • 基于本机构数据,采用最佳实践技术可提供长期可靠的腹膜腔通路,推荐采用这些技术以促进腹膜透析导管的长期存活。

主要发现

  • 4例(0.9%)患者出现需返回手术室的术后即刻并发症,无围手术期死亡。
  • 长期随访的298例(65.2%)患者中,221例(74.2%)仍存活,76例(25.6%)仍在行腹膜透析,63例(21.1%)从腹膜透析转为血液透析,88例(29.5%)已接受肾移植。
  • 基于Kaplan-Meier生存曲线,腹膜透析5.5年后30%的患者将从腹膜透析转为血液透析,从开始腹膜透析到肾移植的中位时间为5.6年。

临床怎么用

  • 在临床中采用最佳实践技术行腹腔镜腹膜透析导管置入,以降低早期并发症并提高导管长期存活率。

局限性

  • 本研究为单中心回顾性研究,长期随访仅298例(65.2%)患者可用,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Peritoneal dialysis as a mode of renal replacement therapy still has not been embraced widely as an alternative to hemodialysis. Furthermore, there is marked variability in peritoneal dialysis catheter insertion techniques and perioperative management within the United States. After the publication of best-demonstrated practices for peritoneal dialysis catheter placement, the utilization of peritoneal dialysis has increased significantly at our institution. We detail the long-term success of peritoneal dialysis catheter placement after the adoption of best-demonstrated practices. METHODS: Retrospective chart review was performed on all patients who underwent laparoscopic peritoneal dialysis catheter placement using the best-demonstrated practice technique from January 2005 through December 2015. Preoperative patient demographic information, intraoperative variables, 30-day morbidity and mortality, and long-term catheter durability outcomes were investigated. RESULTS: A total of 457 patients met inclusion criteria. Four (0.9%) patients experienced an immediate postoperative complication requiring return to the operating room. There were no perioperative mortalities. A total of 298 (65.2%) patients were available for long-term follow-up; 221 (74.2%) patients are still alive, 76 (25.6%) patients are still undergoing peritoneal dialysis, 63 (21.1%) patients transitioned from peritoneal dialysis to hemodialysis, and 88 (29.5%) patients have undergone kidney transplantation. Based on Kaplan-Meier survival plots, 30% of patients will transition from peritoneal dialysis to hemodialysis after 5.5 years of peritoneal dialysis and the median time from commencing peritoneal dialysis to kidney transplantation is 5.6 years. CONCLUSION: Based on our institutional data, the adoption of best-demonstrated practices should provide long-term and reliable access to the peritoneal cavity. We recommend the adoption of these techniques to facilitate long-term peritoneal dialysis catheter survival.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Haskins IN, Schreiber M, Prabhu AS, et al. Peritoneal dialysis catheter placement as a mode of renal replacement therapy: Long-term results from a tertiary academic institution. Surgery. 2017. PMID: 28867046. doi:10.1016/j.surg.2017.07.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。